Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
KNMD On Other Exchanges
Symbol
Exchange
NASDAQ GM
All times are local (Market data is delayed by at least 15 minutes).

kinemed inc (KNMD) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
16.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for KINEMED INC (KNMD)

Related News

No related news articles were found.

kinemed inc (KNMD) Related Businessweek News

No Related Businessweek News Found

kinemed inc (KNMD) Details

KineMed, Inc. develops and commercializes proprietary biomarker platform technology. The company focuses on applying its proprietary biomarker platform technology to drug development, prescription, and non-prescription medical diagnostics and the pairing of drugs with diagnostic biomarker tests. It plans to commercialize biomarkers in the areas of muscle biology, fibrotic diseases, neurodegenerative diseases, cardiometabolic diseases, skin care, and cancer. The company was founded in 2001 and is based in Emeryville, California.

49 Employees
Last Reported Date: 06/9/14
Founded in 2001

kinemed inc (KNMD) Top Compensated Officers

Co-Founder, Chairman and Chief Executive Offi...
Total Annual Compensation: --
Co-Founder, Chairman of the Scientific Adviso...
Total Annual Compensation: --
Chief Financial Officer
Total Annual Compensation: --
Chief Operating Officer
Total Annual Compensation: --
Chief Business Officer and Executive Vice Pre...
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

kinemed inc (KNMD) Key Developments

KineMed, Inc. and Camino Partnership, LLC Announce a Strategic Partnership

KineMed, Inc. and Camino Partnership, LLC announced they are entering into a strategic partnership to locate and acquire control of a portfolio of new drug and targeted drug candidates. Once acquired, the collaboration will apply KineMed's dynamic proteomics technology to carry out rapid proof-of-concept clinical studies for subsequent out-licensing to pharmaceutical companies. The initial therapeutic areas of focus will be oncology, neurodegenerative disorders, muscle wasting and fibrosis, particularly fibrosis of the liver. The collaboration intends to carry out de-risking proof-of-concept studies on up to six compounds over a three-year period.

KineMed, Inc. Presents at 8th Annual EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITION, Mar-03-2015 through Mar-04-2015

KineMed, Inc. Presents at 8th Annual EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITION, Mar-03-2015 through Mar-04-2015. Venue: Hilton, Zurich Airport Hotel, Hohenbuehlstrasse 10, Opfikon-Glattbrugg 8152 Zurich, Zurich, Switzerland. Presentation Date & Speakers: Mar-03-2015, Patrick James Doyle, Chief Business Officer and Executive Vice President.

KineMed, Inc. Presents at BIO-Europe Spring 2015, Mar-10-2015 02:45 PM

KineMed, Inc. Presents at BIO-Europe Spring 2015, Mar-10-2015 02:45 PM. Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KNMD:US $0.00 USD 0.00

KNMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KNMD.
View Industry Companies
 

Industry Analysis

KNMD

Industry Average

Valuation KNMD Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KINEMED INC, please visit www.kinemed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.